Sarah James
Stock Analyst at Cantor Fitzgerald
(2.08)
# 2,883
Out of 4,761 analysts
274
Total ratings
31.28%
Success rate
-1.6%
Average return
Main Sectors:
Stocks Rated by Sarah James
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
THC Tenet Healthcare | Reiterates: Overweight | $177 | $137.24 | +28.97% | 20 | Feb 13, 2025 | |
HUM Humana | Reiterates: Neutral | $290 | $271.30 | +6.89% | 20 | Feb 12, 2025 | |
CI The Cigna Group | Maintains: Overweight | $400 → $350 | $299.68 | +16.79% | 20 | Jan 31, 2025 | |
HCA HCA Healthcare | Reiterates: Overweight | $405 | $321.50 | +25.97% | 19 | Jan 27, 2025 | |
ELV Elevance Health | Reiterates: Overweight | $485 | $390.50 | +24.20% | 19 | Jan 24, 2025 | |
UNH UnitedHealth Group | Reiterates: Overweight | $700 | $502.42 | +39.33% | 17 | Jan 17, 2025 | |
CNC Centene | Reiterates: Overweight | $90 | $58.48 | +53.90% | 12 | Dec 11, 2024 | |
ACHC Acadia Healthcare Company | Reiterates: Neutral | $52 | $40.67 | +27.86% | 13 | Dec 10, 2024 | |
PGNY Progyny | Maintains: Overweight | $30 → $17 | $23.88 | -28.81% | 14 | Nov 14, 2024 | |
UHS Universal Health Services | Reiterates: Neutral | $219 | $184.17 | +18.91% | 24 | Oct 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $406 | $291.46 | +39.30% | 11 | Oct 24, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $13 | $27.92 | -53.44% | 5 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $43 | $25.67 | +67.51% | 12 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $16 | $5.39 | +196.85% | 6 | Oct 4, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $62 | $65.09 | -4.75% | 14 | Oct 1, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $15 | $7.52 | +99.47% | 10 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $5 | $5.03 | -0.60% | 8 | Sep 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $10 | $12.69 | -21.20% | 2 | Aug 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $101 | $91.09 | +10.88% | 7 | Jul 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $133 | $145.92 | -8.85% | 6 | Mar 6, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $42 | $20.29 | +107.00% | 3 | Aug 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6 → $5 | $3.35 | +49.25% | 2 | Sep 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $4.83 | +3.52% | 2 | Aug 19, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $21 | $14.37 | +46.14% | 3 | Aug 8, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $39 | $62.67 | -37.77% | 1 | Aug 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $193 | $78.05 | +147.28% | 2 | Sep 15, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.54 | - | 2 | Mar 1, 2017 |
Tenet Healthcare
Feb 13, 2025
Reiterates: Overweight
Price Target: $177
Current: $137.24
Upside: +28.97%
Humana
Feb 12, 2025
Reiterates: Neutral
Price Target: $290
Current: $271.30
Upside: +6.89%
The Cigna Group
Jan 31, 2025
Maintains: Overweight
Price Target: $400 → $350
Current: $299.68
Upside: +16.79%
HCA Healthcare
Jan 27, 2025
Reiterates: Overweight
Price Target: $405
Current: $321.50
Upside: +25.97%
Elevance Health
Jan 24, 2025
Reiterates: Overweight
Price Target: $485
Current: $390.50
Upside: +24.20%
UnitedHealth Group
Jan 17, 2025
Reiterates: Overweight
Price Target: $700
Current: $502.42
Upside: +39.33%
Centene
Dec 11, 2024
Reiterates: Overweight
Price Target: $90
Current: $58.48
Upside: +53.90%
Acadia Healthcare Company
Dec 10, 2024
Reiterates: Neutral
Price Target: $52
Current: $40.67
Upside: +27.86%
Progyny
Nov 14, 2024
Maintains: Overweight
Price Target: $30 → $17
Current: $23.88
Upside: -28.81%
Universal Health Services
Oct 25, 2024
Reiterates: Neutral
Price Target: $219
Current: $184.17
Upside: +18.91%
Oct 24, 2024
Reiterates: Overweight
Price Target: $406
Current: $291.46
Upside: +39.30%
Oct 4, 2024
Reiterates: Overweight
Price Target: $13
Current: $27.92
Upside: -53.44%
Oct 4, 2024
Reiterates: Overweight
Price Target: $43
Current: $25.67
Upside: +67.51%
Oct 4, 2024
Reiterates: Overweight
Price Target: $16
Current: $5.39
Upside: +196.85%
Oct 1, 2024
Reiterates: Neutral
Price Target: $62
Current: $65.09
Upside: -4.75%
Sep 20, 2024
Reiterates: Overweight
Price Target: $15
Current: $7.52
Upside: +99.47%
Sep 20, 2024
Reiterates: Overweight
Price Target: $5
Current: $5.03
Upside: -0.60%
Aug 20, 2024
Reiterates: Overweight
Price Target: $10
Current: $12.69
Upside: -21.20%
Jul 25, 2024
Reiterates: Neutral
Price Target: $101
Current: $91.09
Upside: +10.88%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $133
Current: $145.92
Upside: -8.85%
Aug 22, 2023
Reiterates: Overweight
Price Target: $42
Current: $20.29
Upside: +107.00%
Sep 15, 2022
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $3.35
Upside: +49.25%
Aug 19, 2022
Maintains: Overweight
Price Target: $7 → $5
Current: $4.83
Upside: +3.52%
Aug 8, 2022
Maintains: Overweight
Price Target: $14 → $21
Current: $14.37
Upside: +46.14%
Aug 12, 2021
Initiates: Overweight
Price Target: $39
Current: $62.67
Upside: -37.77%
Sep 15, 2017
Upgrades: Overweight
Price Target: $193
Current: $78.05
Upside: +147.28%
Mar 1, 2017
Downgrades: Underweight
Price Target: n/a
Current: $3.54
Upside: -